• Home
  • Aim of this blog

Dr.S.Venkatesan MD

Expressions in cardiology

Feeds:
Posts
Comments
« “Dialysable LV dysfunction In CKD ” : Myocardial edema clearance plays a role.
All time best quote on “Principles of learning and education “ »

DAPT blues in ACS : Does Prasugrel really bother to know about the coronary anatomy before it acts ?

October 19, 2020 by dr s venkatesan

It appears,antiplatelet agents are waging a turf war on the CAD battlefield. It is no secret either, the fight often goes beyond academic reasons. Though NSTEMI connotes a true cardiac emergency, it consists of a highly heterogeneous population. A patient with UA can be treated even at home (Low-grade angina with little ECG changes, when it’s due to Increase demand situation). While, in the other extreme of NSTEMI, a patient with a GRACE score >200, in Ischemic  LVF, might need an emergency multivessel angioplasty along with Mitra clip ±  ECMO support. 

Antiplatelet agents along with heparin will remain the cornerstone* in the management of NSTEMI/NSTEACS, irrespective of our fine catheter skills within index lesion. They are administered right from the pre-hospital phase/ In ER, CCU/ or on way to the cath lab(upstream)/or within the cath lab/or after CAG /PCI.  It is the right balance between the prevention of stent-related coronary thrombus vs systemic bleed we are worried about. Definitely, DAPT is warranted. (See the chart below) Prasugrel has been reinvented as the most powerful P2/Y12 blocking antiplatelet agent. It squarely beats its other colleague drugs like Aspirin, Clopidogrel, and Ticagrelor in terms of potency as well as its risk of a bleed. This is the current antiplatelet protocol in NSTEMI in a patient planned for PCI after visualizing the coronary anatomy. Note, Aspirin plus Prasugrel combination occupies the top slot among various options. The principle of DAPT strategy is all about Initial escalation to match the heightened risk of thrombosis/ cardiac events and later de-escalate once the risk period is over (Which can vary between 1 month to 12 months or even 2 years)* The popular concept of attributing NSTEMI to platelet clot and STEMI to fibrin clot is no longer valid. The contribution of the individual component(white vs red)  in a given load of coronary thrombus was never quantified accurately. That’s why antiplatelet agents alone are grossly inadequate in NSTEMI. This will be vouched by this NSTEMI algorithm, which begins with red clot busters heparin. 

So, how to handle sharp-edged drug-like Prasugrel?

A powerful drug-like Prasugrel is at high risk of being misused. It has taught us some harsh lessons in stroke. So, we have to be wiser to extract the maximum out of this drug in the presence of a high thrombotic milieu (or at risk of developing it after a PCI.)

Since ECG and clinical features are not sufficient to predict the coronary thrombus. It is suggested to have a look at coronary anatomy and decide only if a PCI is contemplated.Some of the situations where Prasugrel is likely to be Indicated  

  • Any PCI with a stent in the culprit artery.
  • High  thrombus load
  • Prolonged procedure time

     

    When to Avoid Prasugrel?

    Just looking at coronary anatomy is not sufficient.  Estimating the risk of bleeding is required. Attempting to use various scoring systems during a cardiac emergency is a self-inflicted mathematical burden. In my opinion, none of these scoring systems(CRUSADE , ACUITY,  ARC-HBR) truly discriminate patients in a useful way. Mindfulness with an eye on co-morbid conditions is required.This has to be matched with coronary lesion /PCI complexity. Realistically, the confidence in our technical adequacy of stent deployment shall decide the need for aggressive post PCI  DAPT or anticoagulation

Final message

Just because we know the coronary anatomy, don’t expect prasugrel to be kind enough to lower the risk of stroke. The risk is the same whether we know anatomy or not. It is the funny evidence base we have created that makes us believe it so. Routine DAPT for all patients with ACS is not warranted without assessing the bleeding risk. Meanwhile, there can be an important subset of patients who can really benefit from prasugrel even within coronary care units who are unplanned for PCI. (Which the current guidelines seem to forbid without any valid reason)

Postamble

We know, stents love to befriend thrombus instantly, that demands aggressive antiplatelet/anticoagulants) which beget bleeding. So, should we stent all lesions in a given patient with NSTEMI ? is a very valid question (rarely asked though) needs to be answered by the custodians of patients’ heart. When dealing with a complex PCI case scenario, simple mindfulness with an eye on comorbid conditions and downgrading ourselves to a good general physician mindset is welcome.

Reference

1.The DUBIUS trial downstream vs upstream use of antiplatelet agents in NSTEACS- No difference

https://www.acc.org/latest-in-cardiology/clinical-trials/2020/08/31/21/44/dubius

 

 

 2.

Rate this:

Share this:

  • LinkedIn
  • WhatsApp
  • Twitter
  • Facebook
  • Email

Like this:

Like Loading...

Related

Posted in acute coronary syndrome, oral anticoagulants warfarin acitrom, prasugrel | Tagged 2b3a vs prasugrel, coronary anatomy in nsteacs dapt mapt, NSTEMI guidelines esc acc 2020, prasugrel vs aspirin vs ticagrelor, reopro vs prasugrel, themis twilight study |

  • Categories

  • Archives

    • January 2023 (7)
    • December 2022 (3)
    • November 2022 (5)
    • October 2022 (5)
    • September 2022 (4)
    • August 2022 (3)
    • July 2022 (9)
    • June 2022 (2)
    • May 2022 (1)
    • April 2022 (2)
    • March 2022 (1)
    • February 2022 (3)
    • January 2022 (7)
    • December 2021 (3)
    • November 2021 (5)
    • October 2021 (8)
    • September 2021 (4)
    • August 2021 (6)
    • July 2021 (6)
    • June 2021 (7)
    • May 2021 (5)
    • April 2021 (4)
    • March 2021 (3)
    • February 2021 (6)
    • January 2021 (8)
    • December 2020 (4)
    • November 2020 (5)
    • October 2020 (7)
    • September 2020 (7)
    • August 2020 (10)
    • July 2020 (6)
    • June 2020 (9)
    • May 2020 (9)
    • April 2020 (5)
    • March 2020 (7)
    • February 2020 (3)
    • January 2020 (4)
    • December 2019 (4)
    • November 2019 (6)
    • October 2019 (3)
    • September 2019 (6)
    • August 2019 (3)
    • July 2019 (1)
    • June 2019 (3)
    • May 2019 (2)
    • April 2019 (2)
    • March 2019 (2)
    • February 2019 (4)
    • January 2019 (2)
    • December 2018 (2)
    • November 2018 (2)
    • October 2018 (2)
    • September 2018 (1)
    • August 2018 (2)
    • July 2018 (3)
    • June 2018 (1)
    • May 2018 (3)
    • April 2018 (1)
    • March 2018 (3)
    • February 2018 (3)
    • January 2018 (1)
    • December 2017 (3)
    • November 2017 (3)
    • October 2017 (3)
    • September 2017 (2)
    • August 2017 (2)
    • July 2017 (2)
    • June 2017 (2)
    • May 2017 (4)
    • April 2017 (3)
    • March 2017 (3)
    • February 2017 (5)
    • January 2017 (3)
    • December 2016 (2)
    • November 2016 (5)
    • October 2016 (4)
    • September 2016 (3)
    • August 2016 (5)
    • July 2016 (3)
    • June 2016 (4)
    • May 2016 (3)
    • April 2016 (6)
    • March 2016 (4)
    • February 2016 (3)
    • January 2016 (5)
    • December 2015 (6)
    • November 2015 (5)
    • October 2015 (8)
    • September 2015 (2)
    • August 2015 (5)
    • July 2015 (7)
    • June 2015 (4)
    • May 2015 (6)
    • April 2015 (5)
    • March 2015 (7)
    • February 2015 (15)
    • January 2015 (8)
    • December 2014 (5)
    • November 2014 (9)
    • October 2014 (7)
    • September 2014 (9)
    • August 2014 (5)
    • July 2014 (11)
    • June 2014 (5)
    • May 2014 (4)
    • April 2014 (5)
    • March 2014 (8)
    • February 2014 (8)
    • January 2014 (5)
    • December 2013 (7)
    • November 2013 (7)
    • October 2013 (14)
    • September 2013 (12)
    • August 2013 (15)
    • July 2013 (15)
    • June 2013 (15)
    • May 2013 (15)
    • April 2013 (15)
    • March 2013 (15)
    • February 2013 (15)
    • January 2013 (15)
    • December 2012 (15)
    • November 2012 (15)
    • October 2012 (15)
    • September 2012 (15)
    • August 2012 (15)
    • July 2012 (15)
    • June 2012 (15)
    • May 2012 (15)
    • April 2012 (15)
    • March 2012 (15)
    • February 2012 (15)
    • January 2012 (15)
    • December 2011 (15)
    • November 2011 (17)
    • October 2011 (17)
    • September 2011 (17)
    • August 2011 (21)
    • July 2011 (20)
    • June 2011 (17)
    • May 2011 (15)
    • April 2011 (17)
    • March 2011 (25)
    • February 2011 (20)
    • January 2011 (20)
    • December 2010 (18)
    • November 2010 (21)
    • October 2010 (21)
    • September 2010 (25)
    • August 2010 (20)
    • July 2010 (10)
    • June 2010 (11)
    • May 2010 (19)
    • April 2010 (16)
    • March 2010 (14)
    • February 2010 (22)
    • January 2010 (18)
    • December 2009 (20)
    • November 2009 (20)
    • October 2009 (3)
    • September 2009 (21)
    • August 2009 (19)
    • July 2009 (12)
    • June 2009 (12)
    • May 2009 (11)
    • April 2009 (15)
    • March 2009 (21)
    • February 2009 (4)
    • January 2009 (12)
    • December 2008 (13)
    • November 2008 (9)
    • October 2008 (22)
    • September 2008 (20)
    • August 2008 (16)
    • July 2008 (14)
    • June 2008 (7)
  • Blog Stats

    • 5,957,360 hits
  • Please give your feed back .

  • Click below to see who is watching this website live !

  • This site will never aim for profit. Still ,this donation link is added at the request of few visitors who wanted to contribute and of-course that will help make it sustainable . Donate Button with Credit Cards
  • Please Note

    The author acknowledges all the queries posted by the readers and wishes to answer them .Due to logistic reasons only few could be responded. Inconvenience caused is regretted.
  • Live 3D global traffic map Stats

WPThemes.


  • Follow Following
    • Dr.S.Venkatesan MD
    • Join 820 other followers
    • Already have a WordPress.com account? Log in now.
    • Dr.S.Venkatesan MD
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d bloggers like this: